In a report released today, Uy Ear from Mizuho Securities maintained a Buy rating on Cabaletta Bio (CABA - Research Report), with a price target of $10.00. The company's shares closed last Friday at $0.94.According to TipRanks, Ear is a 2-star analyst with an average return of 1.5% and a 47.22% success rate. Ear covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, ACADIA Pharmaceuticals, and Revance Therapeutics.The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cabaletta Bio with a $9.25 average price target.
https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-cabaletta-bio-caba?utm_source=advfn.com&utm_medium=referral
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Cabaletta Bio Charts.
Cabaletta Bio (NASDAQ:CABA)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Cabaletta Bio Charts.